"Attack of the Mutant Head Lice:" Now playing in 25 states.

Just 2 days after the FDA approved the female libido enhancer flibanserin (Addyi), Valeant Pharmaceuticals paid $1 billion for the company that developed the drug.

Everything you ever wanted to know about flibanserin, courtesy of an FAQ from The Onion.

Affordable Care Act 1: Good drug prices for the uninsured, but bad for Wal-Mart's profits.

ACA 2: Why GOP presidential candidates' plans to "reform" it will never work.

Health concerns have started to crop up in advance of the 2016 Olympics in Rio de Janeiro.

Colorado is stepping up efforts to warn teens about the effects of pot, including a health message of sorts in the campaign.

Women with ductal carcinoma in situ have a low risk of dying of breast cancer, but several factors can increase the risk.

The Surgeon General has no second thoughts about characterizing gun violence as a public health issue.

Associated Press reports that Coca Cola will publish a list of health partnerships as part of its controversial funding program for health research.

Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.